Meagan Lantz, PA
Physician Assistant · Pleasanton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Meagan Lantz’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence G62969 · Cancelled
Licence status: Cancelled · since 1988 · University of California, Los Angeles School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$2,899
Medicare paid this office $2,899 for 21 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Coronary artery bypass graft (CABG) | 11 | More than 43% of doctors who do this |
Who their Medicare patients are
21 Original Medicare patients in 2024. Average age 76 · Health risk score 1.95. Above the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75% · Coronary heart disease 75% · Atrial fibrillation 75% · Heart failure 71% · Chronic kidney disease 57% · Diabetes 52%.
The office billed $72,941, Medicare allowed $4,703 and paid $2,899; for 33 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Money from drug and device companies
$2,605 in 2025
| 2025 | 4 | 32 | None | $2,605 |
| 2024 | 4 | 9 | None | $461 |
| 2023 | 1 | 1 | None | $98 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AtriCure | Epi-Sense Guided Coagulation System With Visitrax | $1,489 | 13 payments
|
| Getinge USA Sales | Vasoview Hemopro 2 | $774 | 7 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $262 | 9 payments
|
| Abiomed | None | $81 | 3 payments
|
See all 32 published payments
| AtriCure | Meals · 2025-12-17 | Atriclip Laa Exclusion System | $31 |
| Edwards Lifesciences | Meals · 2025-12-09 | Sapien 3 Ultra Resilia | $22 |
| Getinge USA Sales | Travel · 2025-11-15 | Vasoview Hemopro 2 | $196 |
| Edwards Lifesciences | Meals · 2025-11-11 | Sapien 3 Ultra Resilia | $21 |
| AtriCure | Travel · 2025-10-04 | Epi-Sense Guided Coagulation System With Visitrax | $312 |
| AtriCure | Travel · 2025-10-01 | Epi-Sense Guided Coagulation System With Visitrax | $241 |
| AtriCure | Meals · 2025-10-01 | Epi-Sense Guided Coagulation System With Visitrax | $71 |
| AtriCure | Meals · 2025-10-01 | Epi-Sense Guided Coagulation System With Visitrax | $94 |
| AtriCure | Meals · 2025-10-01 | Epi-Sense Guided Coagulation System With Visitrax | $39 |
| AtriCure | Meals · 2025-09-30 | Epi-Sense Guided Coagulation System With Visitrax | $153 |
| AtriCure | Travel · 2025-09-30 | Epi-Sense Guided Coagulation System With Visitrax | $293 |
| AtriCure | Meals · 2025-09-30 | Epi-Sense Guided Coagulation System With Visitrax | $44 |
| Abiomed | Meals · 2025-09-09 | None | $34 |
| Edwards Lifesciences | Meals · 2025-08-19 | Sapien 3 Ultra Resilia | $34 |
| Edwards Lifesciences | Meals · 2025-08-05 | Sapien 3 Ultra Resilia | $22 |
| Edwards Lifesciences | Meals · 2025-08-05 | Mitris Resilia Mitral Valve | $62 |
| AtriCure | Meals · 2025-07-30 | Atriclip Laa Exclusion System | $20 |
| Edwards Lifesciences | Meals · 2025-07-15 | Sapien 3 Ultra Resilia | $36 |
| AtriCure | Travel · 2025-06-27 | Epi-Sense Guided Coagulation System With Visitrax | $153 |
| Edwards Lifesciences | Meals · 2025-05-13 | Sapien 3 Ultra Resilia | $27 |
| AtriCure | Meals · 2025-04-22 | Atriclip Laa Exclusion System | $8 |
| Edwards Lifesciences | Meals · 2025-04-15 | Sapien 3 Ultra Resilia | $18 |
| AtriCure | Meals · 2025-04-08 | Synergy Ablation System | $29 |
| Getinge USA Sales | Meals · 2025-04-07 | Vasoview Hemopro 2 | $25 |
| Abiomed | Meals · 2025-03-07 | None | $15 |
| Abiomed | Meals · 2025-03-06 | None | $32 |
| Getinge USA Sales | Travel · 2025-02-11 | Vasoview Hemopro 2 | $397 |
| Edwards Lifesciences | Meals · 2025-02-11 | Sapien 3 Ultra Resilia | $20 |
| Getinge USA Sales | Meals · 2025-01-29 | Vasoview Hemopro 2 | $11 |
| Getinge USA Sales | Meals · 2025-01-28 | Vasoview Hemopro 2 | $16 |
| Getinge USA Sales | Meals · 2025-01-28 | Vasoview Hemopro 2 | $21 |
| Getinge USA Sales | Meals · 2025-01-27 | Vasoview Hemopro 2 | $108 |
See earlier years (2024, 2023)
2024: $461
| Medical Device Business Services | Vistaseal | $163 | 3 payments
|
| Becton Dickinson and | Progel Applicator Spray Tips | $135 | 1 payment
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $125 | 4 payments
|
| Getinge USA Sales | Vasoview Hemopro 2 | $38 | 1 payment
|
2023: $98
| Medical Device Business Services | None | $98 | 1 payment
|
Professional record
- NPI
- 1760187538
- Licence
- CA 62969California G62969: Cancelled
- Group
- Stanford Health Care
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 300 Pasteur Dr, Palo Alto, CA, 94305
- NPI first listed
- 2023-04-03
- NPI last updated
- 2024-01-22
- NPI record certified
- 2024-01-22
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 715 Partridge Ave, Menlo Park, CA, 94025